Neuroleptic Malignant Syndrome in a Patient With Anti-N-Methyl-D-Aspartate Receptor Encephalitis: Case Report and Review of Related Literature.
Robert Joseph Cruz SarmientoJose Danilo B DiestroAthena Kate D AntonioMario B PradoKaren Joy B AdiaoCarissa Paz Dioquino-MaligasoPublished in: The Neurohospitalist (2021)
Anti- NMDAR encephalitis patients are at risk for NMS due to antipsychotic intolerance and other interrelated pathophysiological mechanisms. The overlap between the signs and symptoms of anti-NMDAR encephalitis and NMS poses a diagnostic dilemma and warrants a careful investigation and management.